Anastrozole and CJC-1295 with DAC Interaction
Anastrozole and CJC-1295 with DAC have a synergistic interaction with 60% confidence. CJC-1295 with DAC helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. Both compounds affect the pituitary, so monitoring these systems is recommended.
Compound Profiles
Anastrozole
Aromatase Inhibitor | Estrogen Management
Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.
View full profileCJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Anastrozole with CJC-1295 with DAC?
Yes, Anastrozole and CJC-1295 with DAC can generally be taken together. CJC-1295 with DAC helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.
Is Anastrozole and CJC-1295 with DAC safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: estrogenic. Monitor accordingly.
What are the interactions between Anastrozole and CJC-1295 with DAC?
CJC-1295 with DAC helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.
How should I time Anastrozole and CJC-1295 with DAC?
Anastrozole has a half-life of ~40-50 hours and CJC-1295 with DAC has a half-life of 6-8 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.